Back to Search
Start Over
Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results.
- Source :
- Leukemia & Lymphoma; Jan2009, Vol. 50 Issue 1, p114-118, 5p, 1 Chart, 1 Graph
- Publication Year :
- 2009
-
Abstract
- A letter to the editor is presented which discusses a study on the impact of additional cytogenetic abnormalities (ACA) on the response and survival of patients with late chronic phase chronic myeloid leukemia (CML), who were treated with the Bcr-Abl tyrosine kinase imatinib mesylate.
- Subjects :
- LETTERS to the editor
CHRONIC myeloid leukemia
Subjects
Details
- Language :
- English
- ISSN :
- 10428194
- Volume :
- 50
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Leukemia & Lymphoma
- Publication Type :
- Academic Journal
- Accession number :
- 36243985
- Full Text :
- https://doi.org/10.1080/10428190802492415